About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Prkci
protein kinase C, iota
MGI:99260
78 phenotypes from 7 alleles in 9 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Prkcitm1.1Rfar/Prkcitm1.1Rfar
involves: 129P2/OlaHsd * BALB/cJ * NMRI 		abnormal cell morphology J:202124
abnormal head fold morphology J:202124
abnormal heart tube morphology J:202124
abnormal mesoderm development J:202124
abnormal proximal-distal axis patterning J:202124
abnormal rostral-caudal axis patterning J:202124
absent allantois J:202124
absent heart tube J:202124
absent somites J:202124
embryonic growth retardation J:202124
embryonic lethality during organogenesis, complete penetrance J:202124
small allantois J:202124
small amniotic cavity J:202124
thick embryonic epiblast J:202124
Prkcitm1Hed/Prkcitm1Hed
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 		abnormal cell morphology J:92719
embryonic lethality, complete penetrance J:92719
Prkcitm1Kido/Prkcitm1.1Kido
Tg(Cryaa-cre)10Mlr/?
involves: FVB/N 		abnormal anterior eye segment morphology J:154910
abnormal iris morphology J:154910
abnormal iris pigment epithelium J:154910
abnormal lens epithelium morphology J:154910
abnormal lens morphology J:154910
disorganized secondary lens fibers J:154910
microphthalmia J:154910
pupil opacity J:154910
small pupil J:154910
Prkcitm1Kido/Prkcitm1.1Kido
Tg(Nphs1-cre)33Mska/0
involves: C57BL/6 * C57BL/6N * DBA/2 		abnormal podocyte morphology J:144995
abnormal podocyte polarity J:144995
abnormal podocyte slit diaphragm morphology J:144995
abnormal podocyte slit junction morphology J:144995
abnormal proximal convoluted tubule morphology J:144995
abnormal renal glomerulus morphology J:144995
decreased podocyte number J:144995
detached podocyte J:144995
dilated glomerular capillary J:144995
expanded mesangial matrix J:144995
fused podocyte foot processes J:144995
glomerulosclerosis J:144995
increased blood urea nitrogen level J:144995
increased circulating creatinine level J:144995
increased urine protein level J:144995
podocyte foot process effacement J:144995
postnatal growth retardation J:144995
premature death J:144995
renal cast J:144995
renal glomerular synechia J:144995
Prkcitm1Kido/Prkcitm1Kido
Tg(Crx-cre)1Tfur/0
Not Specified 		abnormal retina morphology J:102364
abnormal retina photoreceptor morphology J:102364
absent photoreceptor inner segment J:102364
absent photoreceptor outer segment J:102364
hydrocephaly J:102364
microphthalmia J:102364
Prkcitm1Kido/Prkcitm1Kido
Tg(Cryaa-cre)10Mlr/?
involves: FVB/N 		abnormal anterior eye segment morphology J:154910
abnormal iris morphology J:154910
abnormal iris pigment epithelium J:154910
abnormal lens epithelium morphology J:154910
abnormal lens morphology J:154910
disorganized secondary lens fibers J:154910
microphthalmia J:154910
pupil opacity J:154910
small pupil J:154910
Prkcitm1Kido/Prkcitm1Kido
Tg(Ins2-cre)25Mgn/0
involves: 129/Sv * C57BL/6 * DBA/2 		abnormal pancreas secretion J:95378
decreased circulating glucose level J:95378
impaired glucose tolerance J:95378
Prkcitm1Ltg/Prkcitm1Ltg
involves: 129P2/OlaHsd * NMRI 		abnormal head fold morphology J:202124
abnormal heart tube morphology J:202124
abnormal proximal-distal axis patterning J:202124
abnormal rostral-caudal axis patterning J:202124
absent allantois J:202124
absent heart tube J:202124
absent somites J:202124
embryonic growth retardation J:202124
embryonic lethality during organogenesis, complete penetrance J:202124
small allantois J:202124
small amniotic cavity J:202124
thick embryonic epiblast J:202124
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
involves: 129P2/OlaHsd * C57BL/6 * FVB 		abnormal circulating lipid level J:123964
abnormal glucose homeostasis J:123964
decreased adipocyte glucose uptake J:123964
decreased cardiac muscle cell glucose uptake J:123964
decreased circulating HDL cholesterol level J:123964
decreased muscle cell glucose uptake J:123964
decreased skeletal muscle cell glucose uptake J:123964
hepatic steatosis J:123964
impaired glucose tolerance J:123964
increased body weight J:123964
increased circulating cholesterol level J:123964
increased circulating free fatty acids level J:123964
increased circulating glucose level J:123964
increased circulating insulin level J:123964
increased circulating LDL cholesterol level J:123964
increased circulating leptin level J:123964
increased circulating triglyceride level J:123964
increased food intake J:123964
increased susceptibility to autoimmune diabetes J:123964
insulin resistance J:123964
obese J:123964
pancreatic islet hyperplasia J:123964
Prkcitm1Rfar/Prkcitm1Rfar
Tg(Ckmm-cre)5Khn/0
involves: 129P2/OlaHsd * C57BL/6 * FVB 		abnormal circulating lipid level J:123964
abnormal glucose homeostasis J:123964
decreased adipocyte glucose uptake J:123964
decreased cardiac muscle cell glucose uptake J:123964
decreased circulating HDL cholesterol level J:123964
decreased skeletal muscle cell glucose uptake J:123964
hepatic steatosis J:123964
impaired glucose tolerance J:123964
increased body weight J:123964
increased circulating cholesterol level J:123964
increased circulating free fatty acids level J:123964
increased circulating glucose level J:123964
increased circulating insulin level J:123964
increased circulating LDL cholesterol level J:123964
increased circulating leptin level J:123964
increased circulating triglyceride level J:123964
insulin resistance J:123964
pancreatic islet hyperplasia J:123964
Prkcitm1Rfar/Prkcitm1Rfar
Tg(NPHS2-cre)295Lbh/0
involves: 129P2/OlaHsd * C57BL/6 * SJL 		abnormal podocyte morphology J:164628
abnormal podocyte slit diaphragm morphology J:164628
abnormal podocyte slit junction morphology J:164628
dilated renal tubule J:164628
glomerulosclerosis J:164628
increased urine protein level J:164628
kidney failure J:164628
podocyte foot process effacement J:164628
postnatal growth retardation J:164628
premature death J:164628
renal cast J:164628
Prkcitm2.1(Prkcz)Ltg/Prkcitm2.1(Prkcz)Ltg
involves: 129P2/OlaHsd * NMRI 		embryonic growth retardation J:202124
embryonic lethality during organogenesis, incomplete penetrance J:202124
embryonic lethality, incomplete penetrance J:202124
lethality during fetal growth through weaning, complete penetrance J:202124
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
10/09/2024
MGI 6.24 		The Jackson Laboratory